These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

406 related articles for article (PubMed ID: 33166683)

  • 41. Mutations on COVID-19 diagnostic targets.
    Wang R; Hozumi Y; Yin C; Wei GW
    Genomics; 2020 Nov; 112(6):5204-5213. PubMed ID: 32966857
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Evaluation on the use of Nanopore sequencing for direct characterization of coronaviruses from respiratory specimens, and a study on emerging missense mutations in partial RdRP gene of SARS-CoV-2.
    Chan WS; Au CH; Lam HY; Wang CLN; Ho DN; Lam YM; Chu DKW; Poon LLM; Chan TL; Zee JS; Ma ESK; Tang BSF
    Virol J; 2020 Nov; 17(1):183. PubMed ID: 33225958
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Comparative genome analysis of novel coronavirus (SARS-CoV-2) from different geographical locations and the effect of mutations on major target proteins: An in silico insight.
    Khan MI; Khan ZA; Baig MH; Ahmad I; Farouk AE; Song YG; Dong JJ
    PLoS One; 2020; 15(9):e0238344. PubMed ID: 32881907
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Development of a Parallel Reaction Monitoring Mass Spectrometry Assay for the Detection of SARS-CoV-2 Spike Glycoprotein and Nucleoprotein.
    Cazares LH; Chaerkady R; Samuel Weng SH; Boo CC; Cimbro R; Hsu HE; Rajan S; Dall'Acqua W; Clarke L; Ren K; McTamney P; Kallewaard-LeLay N; Ghaedi M; Ikeda Y; Hess S
    Anal Chem; 2020 Oct; 92(20):13813-13821. PubMed ID: 32966064
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Early trends for SARS-CoV-2 infection in central and north Texas and impact on other circulating respiratory viruses.
    Mutnal MB; Arroliga AC; Walker K; Mohammad A; Brigmon MM; Beaver RM; Midturi JK; Rao A
    J Med Virol; 2020 Oct; 92(10):2130-2138. PubMed ID: 32410236
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Detection of SARS-CoV-2 spike protein D614G mutation using μTGGE.
    Juma KM; Morimoto K; Sharma V; Sharma K; Biyani R; Biyani M; Takita T; Yasukawa K
    Mol Biol Rep; 2024 Feb; 51(1):289. PubMed ID: 38329653
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Comprehensive Analyses of SARS-CoV-2 Transmission in a Public Health Virology Laboratory.
    Zuckerman NS; Pando R; Bucris E; Drori Y; Lustig Y; Erster O; Mor O; Mendelson E; Mandelboim M
    Viruses; 2020 Aug; 12(8):. PubMed ID: 32764372
    [TBL] [Abstract][Full Text] [Related]  

  • 48. In silico studies on the comparative characterization of the interactions of SARS-CoV-2 spike glycoprotein with ACE-2 receptor homologs and human TLRs.
    Choudhury A; Mukherjee S
    J Med Virol; 2020 Oct; 92(10):2105-2113. PubMed ID: 32383269
    [TBL] [Abstract][Full Text] [Related]  

  • 49. SARS-COV-2 and infectivity: Possible increase in infectivity associated to integrin motif expression.
    Tresoldi I; Sangiuolo CF; Manzari V; Modesti A
    J Med Virol; 2020 Oct; 92(10):1741-1742. PubMed ID: 32246503
    [No Abstract]   [Full Text] [Related]  

  • 50. Automated SARS-COV-2 RNA extraction from patient nasopharyngeal samples using a modified DNA extraction kit for high throughput testing.
    Al-Saud H; Al-Romaih K; Bakheet R; Mahmoud L; Al-Harbi N; Alshareef I; Judia SB; Aharbi L; Alzayed A; Jabaan A; Alhadrami H; Albarrag A; Azhar EI; Al-Mozaini MA
    Ann Saudi Med; 2020; 40(5):373-381. PubMed ID: 32954791
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The D614G Virus Mutation Enhances Anosmia in COVID-19 Patients: Evidence from a Systematic Review and Meta-analysis of Studies from South Asia.
    von Bartheld CS; Hagen MM; Butowt R
    ACS Chem Neurosci; 2021 Oct; 12(19):3535-3549. PubMed ID: 34533304
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Source of the COVID-19 pandemic: ecology and genetics of coronaviruses (Betacoronavirus: Coronaviridae) SARS-CoV, SARS-CoV-2 (subgenus Sarbecovirus), and MERS-CoV (subgenus Merbecovirus).].
    Lvov DK; Alkhovsky SV
    Vopr Virusol; 2020; 65(2):62-70. PubMed ID: 32515561
    [TBL] [Abstract][Full Text] [Related]  

  • 53. SARS-CoV-2: Structural diversity, phylogeny, and potential animal host identification of spike glycoprotein.
    Dabravolski SA; Kavalionak YK
    J Med Virol; 2020 Sep; 92(9):1690-1694. PubMed ID: 32374452
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Spike protein D614G and RdRp P323L: the SARS-CoV-2 mutations associated with severity of COVID-19.
    Biswas SK; Mudi SR
    Genomics Inform; 2020 Dec; 18(4):e44. PubMed ID: 33412760
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A rapid screening assay for L452R and T478K spike mutations in SARS-CoV-2 Delta variant using high-resolution melting analysis.
    Aoki A; Adachi H; Mori Y; Ito M; Sato K; Okuda K; Sakakibara T; Okamoto Y; Jinno H
    J Toxicol Sci; 2021; 46(10):471-476. PubMed ID: 34602531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Artificial intelligence predicts the immunogenic landscape of SARS-CoV-2 leading to universal blueprints for vaccine designs.
    Malone B; Simovski B; Moliné C; Cheng J; Gheorghe M; Fontenelle H; Vardaxis I; Tennøe S; Malmberg JA; Stratford R; Clancy T
    Sci Rep; 2020 Dec; 10(1):22375. PubMed ID: 33361777
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CD147-spike protein is a novel route for SARS-CoV-2 infection to host cells.
    Wang K; Chen W; Zhang Z; Deng Y; Lian JQ; Du P; Wei D; Zhang Y; Sun XX; Gong L; Yang X; He L; Zhang L; Yang Z; Geng JJ; Chen R; Zhang H; Wang B; Zhu YM; Nan G; Jiang JL; Li L; Wu J; Lin P; Huang W; Xie L; Zheng ZH; Zhang K; Miao JL; Cui HY; Huang M; Zhang J; Fu L; Yang XM; Zhao Z; Sun S; Gu H; Wang Z; Wang CF; Lu Y; Liu YY; Wang QY; Bian H; Zhu P; Chen ZN
    Signal Transduct Target Ther; 2020 Dec; 5(1):283. PubMed ID: 33277466
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Molecular characterization and the mutation pattern of SARS-CoV-2 during first and second wave outbreaks in Hiroshima, Japan.
    Ko K; Nagashima S; E B; Ouoba S; Akita T; Sugiyama A; Ohisa M; Sakaguchi T; Tahara H; Ohge H; Ohdan H; Kubo T; Kishita E; Kuwabara M; Takahashi K; Tanaka J
    PLoS One; 2021; 16(2):e0246383. PubMed ID: 33544733
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Analysis of Indian SARS-CoV-2 Genomes Reveals Prevalence of D614G Mutation in Spike Protein Predicting an Increase in Interaction With TMPRSS2 and Virus Infectivity.
    Raghav S; Ghosh A; Turuk J; Kumar S; Jha A; Madhulika S; Priyadarshini M; Biswas VK; Shyamli PS; Singh B; Singh N; Singh D; Datey A; Avula K; Smita S; Sabat J; Bhattacharya D; Kshatri JS; Vasudevan D; Suryawanshi A; Dash R; Senapati S; Beuria TK; Swain R; Chattopadhyay S; Syed GH; Dixit A; Prasad P; ; ; Pati S; Parida A
    Front Microbiol; 2020; 11():594928. PubMed ID: 33329480
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Association of Clinical Features with Spike Glycoprotein Mutations in Iranian COVID-19 Patients.
    Ahangarzadeh S; Yousefi A; Ranjbar MM; Dabiri A; Zarepour A; Sadeghi M; Heidari E; Mazrui F; Hosseinzadeh M; Ataei B; Zarrabi A; Shariati L; Haghjooy Javanmard S
    J Clin Med; 2022 Oct; 11(21):. PubMed ID: 36362544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.